Home » Topics » BioWorld Science

BioWorld Science
RSS

Roussel Uclaf discloses integrin antagonists for bone disorders

Nov. 26, 1997

Takeda develops potassium channel openers for cardiovascular indications

Nov. 26, 1997

New agents for heart disease prepared by Dainippon Ink & Chemicals

Nov. 26, 1997

Milestone reached in antiinfectives alliance

Nov. 26, 1997

ProLease hGH slated to enter phase III

Nov. 26, 1997

ImmuLogic restructures its operations

Nov. 26, 1997

Sertoli and Carolinas Medical Center collaborate to develop novel diabetes therapy

Nov. 26, 1997

NINDS study links herpesvirus strain to MS

Nov. 26, 1997

Results from Leuvectin trial in kidney cancer patients reported

Nov. 26, 1997

Preliminary results reported for IL-2 gene therapy in GI cancer

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...